Tumor Infiltrating Lymphocytes – The Next Step in Assessing Outcome and Response to Treatment in Patients with Breast Cancer

Tumor infiltrating lymphocytes are studied for their potential as new clinically useful prognostic and predictive biomarkers in patients with triple negative and HER-2/neu amplified breast cancer. This area of research could also help guide the development of novel therapeutic approaches for these d...

Descripción completa

Detalles Bibliográficos
Autores principales: Wesolowski, Robert, Carson, William E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350371/
https://www.ncbi.nlm.nih.gov/pubmed/25750763
http://dx.doi.org/10.4172/2157-2518.1000199
_version_ 1782360183497818112
author Wesolowski, Robert
Carson, William E
author_facet Wesolowski, Robert
Carson, William E
author_sort Wesolowski, Robert
collection PubMed
description Tumor infiltrating lymphocytes are studied for their potential as new clinically useful prognostic and predictive biomarkers in patients with triple negative and HER-2/neu amplified breast cancer. This area of research could also help guide the development of novel therapeutic approaches for these diseases.
format Online
Article
Text
id pubmed-4350371
institution National Center for Biotechnology Information
language English
publishDate 2014
record_format MEDLINE/PubMed
spelling pubmed-43503712015-03-05 Tumor Infiltrating Lymphocytes – The Next Step in Assessing Outcome and Response to Treatment in Patients with Breast Cancer Wesolowski, Robert Carson, William E J Carcinog Mutagen Article Tumor infiltrating lymphocytes are studied for their potential as new clinically useful prognostic and predictive biomarkers in patients with triple negative and HER-2/neu amplified breast cancer. This area of research could also help guide the development of novel therapeutic approaches for these diseases. 2014-11-25 2014-12 /pmc/articles/PMC4350371/ /pubmed/25750763 http://dx.doi.org/10.4172/2157-2518.1000199 Text en Copyright: © 2014 Wesolowski R, et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Article
Wesolowski, Robert
Carson, William E
Tumor Infiltrating Lymphocytes – The Next Step in Assessing Outcome and Response to Treatment in Patients with Breast Cancer
title Tumor Infiltrating Lymphocytes – The Next Step in Assessing Outcome and Response to Treatment in Patients with Breast Cancer
title_full Tumor Infiltrating Lymphocytes – The Next Step in Assessing Outcome and Response to Treatment in Patients with Breast Cancer
title_fullStr Tumor Infiltrating Lymphocytes – The Next Step in Assessing Outcome and Response to Treatment in Patients with Breast Cancer
title_full_unstemmed Tumor Infiltrating Lymphocytes – The Next Step in Assessing Outcome and Response to Treatment in Patients with Breast Cancer
title_short Tumor Infiltrating Lymphocytes – The Next Step in Assessing Outcome and Response to Treatment in Patients with Breast Cancer
title_sort tumor infiltrating lymphocytes – the next step in assessing outcome and response to treatment in patients with breast cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350371/
https://www.ncbi.nlm.nih.gov/pubmed/25750763
http://dx.doi.org/10.4172/2157-2518.1000199
work_keys_str_mv AT wesolowskirobert tumorinfiltratinglymphocytesthenextstepinassessingoutcomeandresponsetotreatmentinpatientswithbreastcancer
AT carsonwilliame tumorinfiltratinglymphocytesthenextstepinassessingoutcomeandresponsetotreatmentinpatientswithbreastcancer

Ejemplares similares